ArticleWellcome open research2021
Development and implementation of a customised rapid syndromic diagnostic test for severe pneumonia.
Open access · goldAbstract read
In one paragraph
Article in Wellcome open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 14 citations in OpenAlex.
- Clinical metagenomics: a call to action.Intensive care medicine · 2026Article
- Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes.Nature communications · 2026Article
- Use of TaqMan array card to investigate bacterial isolates in diabetic foot ulcers.Journal of medical microbiology · 2026Article
- Syndromic diagnostics in pneumonia: the quest for impact continues.Intensive care medicine · 2025Article
- Customised 96-ocular TaqMan (iCAM) microarray PCR card for rapid diagnosis of microbial keratitis.BMJ open ophthalmology · 2024Article
- Bronchoscopic Diagnosis of Severe Respiratory Infections.Journal of clinical medicine · 2024Review
- Rapid syndromic multiplex PCR panels for the management of ventilator-associated lower respiratory tract infections: pondering important limitations. Author's reply.Intensive care medicine · 2024Article
- Enhanced diagnosis of severe bacterial and fungal respiratory infection in children using a rapid syndromic array-case report.Translational pediatrics · 2024Article
- Viral infections in critical care: a narrative review.Anaesthesia · 2023Review
- Living Health Technology Assessment: Issues, Challenges and Opportunities.PharmacoEconomics · 2023Article
- The rapid detection of respiratory pathogens in critically ill children.Critical care (London, England) · 2023Observational
- Rapid Assay for Sick Children with Acute Lung infection Study (RASCALS): diagnostic cohort study protocol.BMJ open · 2021Article
- Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management.Microorganisms · 2021Review
- Ventilator-associated pneumonia in critically ill patients with COVID-19.Critical care (London, England) · 2021Observational
- Development and implementation of a customised rapid syndromic diagnostic test for severe pneumonia.Wellcome open research · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors at 5 institutions in 1 country.
Vilas Navapurkar *John V Farman Intensive Care Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Josefin Bartholdson Scott *Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, CB2 0AW, UK.ORCID https://orcid.org/0000-0003-3380-4446
Mailis MaesCambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, CB2 0AW, UK.
Thomas P HellyerTranslational and Clinical Research Institute, University of Newcastle, Newcastle upon Tyne, NE2 4HH, UK.
Ellen HigginsonCambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, CB2 0AW, UK.
Sally ForrestCambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, CB2 0AW, UK.
Joana Pereira-DiasCambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, CB2 0AW, UK.
Surendra ParmarClinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Emma Heasman-HuntClinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Petra PolgarovaJohn V Farman Intensive Care Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Joanne BrownJohn V Farman Intensive Care Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.ORCID https://orcid.org/0000-0001-7111-6439
Lissamma TittiJohn V Farman Intensive Care Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
William Pw SmithSchool of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, UK.
Jonathan ScottTranslational and Clinical Research Institute, University of Newcastle, Newcastle upon Tyne, NE2 4HH, UK.
Anthony RostronTranslational and Clinical Research Institute, University of Newcastle, Newcastle upon Tyne, NE2 4HH, UK.
Matthew RoutledgeClinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.ORCID https://orcid.org/0000-0003-0423-6857
David SapsfordPharmacy Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
M Estée TörökDepartment of Medicine, University of Cambridge, Cambridge, CB2 0QQ, UK.
Ronan McMullanWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, BT9 7BL, UK.
David A EnochClinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Vanessa WongClinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
VAP-Rapid investigators
Martin D CurranClinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Nicholas M BrownClinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.ORCID https://orcid.org/0000-0002-6657-300X
A John SimpsonTranslational and Clinical Research Institute, University of Newcastle, Newcastle upon Tyne, NE2 4HH, UK.
Jurgen HerreRespiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Gordon DouganCambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, CB2 0AW, UK.
Andrew Conway MorrisJohn V Farman Intensive Care Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.ORCID https://orcid.org/0000-0002-3211-3216
Cambridge University Hospitals NHS Foundation Trust · GBUniversity of Cambridge · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBNewcastle University · GBQueen's University Belfast · GB
Funding
Medical Research Council MR/N029399/1Wellcome Trust 205214/Z/16/Z
Abstract
PubMed holds no abstract for this paper.
Indexed as
Antimicrobial stewardshipCritical CareMolecular pathologyPneumonia
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.